Cresco Labs (CRLBF) Other Non Operating Income (2019 - 2026)
Cresco Labs (CRLBF) reported Other Non Operating Income of $960000.0 for Q1 2026, up 3100.0% on a YoY basis from $30000.0 in Q1 2025, and down 63.96% quarter-over-quarter from $2.7 million in Q4 2025.
Cresco Labs (CRLBF) Other Non Operating Income (2019 - 2026) Analysis & Trends
Cresco Labs has reported Other Non Operating Income for 8 years, with the latest figure at $960000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income rose 3100.0% year-over-year to $960000.0; the trailing twelve-month figure through Mar 2026 stood at -$10.6 million (up 83.15% YoY), and the FY2025 full-year result was -$11.2 million, up 82.38% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $960000.0, down from $2.7 million in the prior quarter.
- The five-year high for Other Non Operating Income was $14.8 million in Q3 2022, with the low at -$59.5 million in Q2 2024.
- Historically, Other Non Operating Income has averaged -$2.9 million across 5 years, with a median of $31000.0 in 2023.
- Annual changes were most pronounced in 2025 — Other Non Operating Income tumbled 267140.0% — and 2026, when it surged 3100.0%.
- Cresco Labs' Other Non Operating Income stood at $2.5 million in 2022, then plunged by 101.98% to -$50000.0 in 2023, then slumped by 6444.0% to -$3.3 million in 2024, then soared by 181.42% to $2.7 million in 2025, then plunged by 63.96% to $960000.0 in 2026.
- The last three Other Non Operating Income figures came in at $960000.0 (Q1 2026), $2.7 million (Q4 2025), and -$13.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Cresco Labs | - | - | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 960,000.00 |
| Dec 31, 2025 | 2.66 Mn |
| Sep 30, 2025 | -13.36 Mn |
| Jun 30, 2025 | -836,000.00 |
| Mar 31, 2025 | 30,000.00 |
| Dec 31, 2024 | -3.27 Mn |
| Sep 30, 2024 | -5,000.00 |
| Jun 30, 2024 | -59.51 Mn |
| Mar 31, 2024 | 856,000.00 |
| Dec 31, 2023 | -50,000.00 |
| Sep 30, 2023 | 329,000.00 |
| Jun 30, 2023 | 402,000.00 |
| Mar 31, 2023 | 31,000.00 |
| Dec 31, 2022 | 2.52 Mn |
| Sep 30, 2022 | 14.80 Mn |
| Jun 30, 2022 | 4.68 Mn |
| Mar 31, 2022 | -69,000.00 |
| Dec 31, 2021 | 10.91 Mn |
| Sep 30, 2021 | 1.74 Mn |
| Jun 30, 2021 | 12.73 Mn |